X |
Filing Date |
Trade Date |
Ticker |
Company Name | Insider Name | Title |
Trade Type |
Price |
Qty |
Owned |
ΔOwn |
Value |
1d |
1w |
1m |
6m |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2025-08-19 | ATRC | Atricure, Inc. | Wehrwein Sven | Dir | S - Sale+OE | $36.00 | -5,000 | 34,374 | -13% | -$180,000 | |||||
| D | 2025-08-19 | BBNX | Beta Bionics, Inc. | Hopman Mark | Chief Commercial Officer | S - Sale+OE | $16.61 | -16,158 | 34,132 | -32% | -$268,376 | |||||
| D | 2025-08-19 | BBNX | Beta Bionics, Inc. | Feider Stephen | CFO | S - Sale+OE | $17.03 | -5,587 | 45,503 | -11% | -$95,172 | |||||
2025-08-19 | RCEL | Avita Medical, Inc. | McNamara Robert | Dir | P - Purchase | $5.00 | +10,000 | 76,771 | +15% | +$50,000 | ||||||
2025-08-18 | SIBN | Si-Bone, Inc. | Recupero Anthony J | Pres, Commercial Ops | S - Sale | $15.62 | -3,833 | 275,288 | -1% | -$59,875 | ||||||
2025-08-18 | SIBN | Si-Bone, Inc. | Pisetsky Michael A. | SVP, Ops, Adm, Chief Legal Ofr | S - Sale | $15.64 | -3,329 | 258,352 | -1% | -$52,055 | ||||||
2025-08-18 | SIBN | Si-Bone, Inc. | Maheshwari Anshul | CFO | S - Sale | $15.57 | -3,461 | 214,445 | -2% | -$53,881 | ||||||
2025-08-18 | SIBN | Si-Bone, Inc. | Francis Laura | CEO | S - Sale | $15.60 | -11,343 | 781,845 | -1% | -$176,940 | ||||||
2025-08-18 | OFIX | Orthofix Medical Inc. | Fisher Patrick | Pres, Global Orthopedics | S - Sale | $14.21 | -1,996 | 30,116 | -6% | -$28,363 | ||||||
2025-08-19 | RVP | Retractable Technologies Inc | Shaw Thomas J | Pres, CEO, 10% | P - Purchase | $0.80 | +9,042 | 16,476,925 | 0% | +$7,200 | ||||||
| D | 2025-08-18 | RMD | Resmed Inc | Hernandez John | Dir | S - Sale+OE | $287.10 | -2,575 | 4,045 | -39% | -$739,289 | |||||
2025-08-18 | RVP | Retractable Technologies Inc | Shaw Thomas J | Pres, CEO, 10% | P - Purchase | $0.80 | +32,935 | 16,467,883 | 0% | +$26,183 | ||||||
2025-08-15 | AORT | Artivion, Inc. | Mackin James P | Pres, CEO | S - Sale | $42.32 | -12,500 | 852,783 | -1% | -$528,988 | ||||||
2025-08-15 | DXCM | Dexcom Inc | Brown Michael Jon | EVP, GC | S - Sale | $80.29 | -500 | 94,102 | -1% | -$40,145 | ||||||
2025-08-15 | DXCM | Dexcom Inc | Foletta Mark G | Dir | S - Sale | $81.06 | -2,750 | 56,852 | -5% | -$222,903 | ||||||
| M | 2025-08-14 | RVP | Retractable Technologies Inc | Shaw Thomas J | Pres, CEO, 10% | P - Purchase | $0.79 | +14,083 | 16,434,948 | 0% | +$11,171 | |||||
2025-08-15 | SOLV | Solventum Corp | 3M Co | 10% | S - Sale | $73.45 | -8,800,000 | 25,569,190 | -26% | -$646,360,000 | ||||||
| D | 2025-08-13 | PEN | Penumbra Inc | Yuen Maggie | CFO | S - Sale+OE | $250.00 | -2,000 | 13,667 | -13% | -$500,000 | |||||
2025-08-13 | PEN | Penumbra Inc | Bose Arani | Dir | S - Sale | $250.65 | -12,000 | 290,819 | -4% | -$3,007,776 | ||||||
2025-08-13 | ATEC | Alphatec Holdings, Inc. | Lish Scott | COO | S - Sale | $16.00 | -9,302 | 665,030 | -1% | -$148,832 | ||||||
2025-08-14 | ICUI | Icu Medical Inc/De | Jain Vivek | COB, CEO | P - Purchase | $112.84 | +21,929 | 218,847 | +11% | +$2,474,375 | ||||||
2025-08-12 | LMAT | Lemaitre Vascular Inc | Jasinski Lawrence J | Dir | S - Sale | $92.78 | -976 | 4,773 | -17% | -$90,553 | ||||||
2025-08-13 | PRCT | Procept Biorobotics Corp | Moll Frederic H | Dir | P - Purchase | $39.26 | +20,000 | 863,159 | +2% | +$785,138 | ||||||
2025-08-14 | RDGL | Vivos Inc | Korenko Michael K | CEO, Pres | P - Purchase | $0.08 | +100,000 | 10,535,090 | +1% | +$7,660 | ||||||
2025-08-13 | RVP | Retractable Technologies Inc | Shaw Thomas J | Pres, CEO, 10% | P - Purchase | $0.80 | +3,983 | 16,424,848 | 0% | +$3,192 | ||||||
2025-08-13 | SRTS | Sensus Healthcare, Inc. | Sardano Michael | Pres, GC | P - Purchase | $3.37 | +1,000 | 116,839 | +1% | +$3,370 | ||||||
| D | 2025-08-12 | AORT | Artivion, Inc. | Holloway Jean F | SVP, GC | S - Sale+OE | $43.01 | -23,356 | 172,129 | -12% | -$1,004,610 | |||||
| D | 2025-08-12 | AORT | Artivion, Inc. | Davis John E | Chief Commercial Officer | S - Sale+OE | $43.67 | -10,802 | 208,778 | -5% | -$471,756 | |||||
2025-08-12 | PEN | Penumbra Inc | Wilder Thomas | Dir | S - Sale | $240.16 | -372 | 4,878 | -7% | -$89,340 | ||||||
2025-08-11 | PEN | Penumbra Inc | Roberts Johanna | EVP, Gen. Counsel, Secretary | S - Sale | $238.94 | -600 | 65,457 | -1% | -$143,363 | ||||||
| D | 2025-08-11 | LMAT | Lemaitre Vascular Inc | Roberts David B | Pres, Dir | S - Sale+OE | $92.39 | -10,815 | 17,976 | -38% | -$999,173 | |||||
2025-08-12 | RVP | Retractable Technologies Inc | Shaw Thomas J | Pres, CEO, 10% | P - Purchase | $0.82 | +8,411 | 16,420,865 | 0% | +$6,922 | ||||||
| D | 2025-08-08 | LMAT | Lemaitre Vascular Inc | Ross Bridget A | Dir | S - Sale+OE | $94.00 | -2,500 | 2,916 | -46% | -$235,000 | |||||
| DM | 2025-08-08 | LMAT | Lemaitre Vascular Inc | Roush John A | Dir | S - Sale+OE | $92.67 | -7,500 | 2,916 | -72% | -$695,015 | |||||
2025-08-08 | TCMD | Tactile Systems Technology Inc | Dodd Sheri Louise | CEO | S - Sale | $12.36 | -7,762 | 173,479 | -4% | -$95,907 | ||||||
2025-08-11 | IRTC | Irhythm Technologies, Inc. | Rosenbaum Marc Wade | Chief Accounting Officer | S - Sale | $158.93 | -226 | 10,879 | -2% | -$35,918 | ||||||
| D | 2025-08-11 | IRTC | Irhythm Technologies, Inc. | Talwalkar Abhijit Y | Dir | S - Sale+OE | $158.02 | -5,312 | 20,299 | -21% | -$839,381 | |||||
2025-08-12 | RCEL | Avita Medical, Inc. | O'Toole David D | CFO | P - Purchase | $4.81 | +2,000 | 29,657 | +7% | +$9,620 | ||||||
2025-08-08 | STIM | Neuronetics, Inc. | Madryn Asset Management, LP | 10% | S - Sale | $3.72 | -3,500,000 | 2,261,168 | -61% | -$13,020,000 | ||||||
| D | 2025-08-11 | MMSI | Merit Medical Systems Inc | Ward Lynne N. | Dir | S - Sale+OE | $84.89 | -2,433 | 12,809 | -16% | -$206,536 | |||||
2025-08-11 | RVP | Retractable Technologies Inc | Shaw Thomas J | Pres, CEO, 10% | P - Purchase | $0.81 | +2,100 | 16,412,454 | 0% | +$1,705 | ||||||
2025-08-11 | TNDM | Tandem Diabetes Care Inc | Sheridan John F | Pres, CEO | P - Purchase | $10.23 | +10,000 | 106,327 | +10% | +$102,318 | ||||||
2025-08-08 | SIBN | Si-Bone, Inc. | Freund John Gordon | Dir | S - Sale | $15.99 | -12,132 | 135,068 | -8% | -$193,998 | ||||||
2025-08-08 | TNDM | Tandem Diabetes Care Inc | Vosseller Leigh | EVP, CFO | P - Purchase | $10.89 | +13,720 | 59,378 | +30% | +$149,404 | ||||||
| D | 2025-08-08 | AORT | Artivion, Inc. | Horton Amy | VP, Chief Accounting Officer | S - Sale+OE | $38.49 | -7,992 | 146,651 | -5% | -$307,612 | |||||
2025-08-11 | BDX | Becton Dickinson & Co | Hayes Gregory | Dir | P - Purchase | $191.57 | +5,250 | 6,046 | +660% | +$1,005,743 | ||||||
2025-08-07 | RVP | Retractable Technologies Inc | Shaw Thomas J | Pres, CEO, 10% | P - Purchase | $0.75 | +49,541 | 16,410,354 | 0% | +$37,007 | ||||||
| D | 2025-08-07 | RMD | Resmed Inc | Farrell Michael J. | CEO | S - Sale+OE | $279.48 | -8,009 | 457,593 | -2% | -$2,238,379 | |||||
| D | 2025-08-06 | PEN | Penumbra Inc | Elsesser Adam | CEO, Pres | S - Sale+OE | $238.20 | -16,030 | 735,786 | -2% | -$3,818,363 | |||||
2025-08-08 | BDX | Becton Dickinson & Co | Fraser Claire | Dir | S - Sale | $192.30 | -863 | 23,143 | -4% | -$165,955 | ||||||
2025-08-06 | LMAT | Lemaitre Vascular Inc | Lemaitre George W | COB, CEO | S - Sale | $93.51 | -100,000 | 1,727,003 | -5% | -$9,350,530 | ||||||
| D | 2025-08-07 | PODD | Insulet Corp | Singh Prem | SVP, Global Operations | S - Sale+OE | $320.00 | -1,343 | 4,143 | -24% | -$429,760 | |||||
2025-08-06 | ATRC | Atricure, Inc. | Groves Regina E | Dir | S - Sale | $36.82 | -2,452 | 33,715 | -7% | -$90,283 | ||||||
| D | 2025-08-07 | MMM | 3M Co | Goralski Christian T Jr | Group Pres | S - Sale+OE | $150.18 | -6,165 | 2,900 | -68% | -$925,860 | |||||
| M | 2025-08-05 | ATEC | Alphatec Holdings, Inc. | Hunsaker Craig E | EVP, PEOPLE, CULTURE | S - Sale | $15.06 | -60,876 | 1,389,142 | -4% | -$916,729 | |||||
2025-08-05 | TFX | Teleflex Inc | Randle Stuart A | Dir | P - Purchase | $115.86 | +1,000 | 7,547 | +15% | +$115,860 | ||||||
2025-08-06 | IRTC | Irhythm Technologies, Inc. | Patterson Chad | Chief Commercial Officer | S - Sale | $158.97 | -2,555 | 43,667 | -6% | -$406,168 | ||||||
2025-08-06 | SYK | Stryker Corp | Stryker Ronda E | Dir | S - Sale | $376.45 | -200,000 | 16,839,726 | -1% | -$75,289,655 | ||||||
2025-08-05 | TFX | Teleflex Inc | Krakauer Andrew A | Dir | P - Purchase | $115.25 | +1,000 | 7,192 | +16% | +$115,250 | ||||||
2025-08-05 | TFX | Teleflex Inc | Kelly Liam | COB, Pres, CEO | P - Purchase | $115.07 | +1,500 | 64,584 | +2% | +$172,605 | ||||||
2025-08-05 | TFX | Teleflex Inc | Ryu Jaewon | Dir | P - Purchase | $115.00 | +1,500 | 3,727 | +67% | +$172,500 | ||||||
2025-08-06 | TFX | Teleflex Inc | Haggerty Gretchen R | Dir | P - Purchase | $114.75 | +500 | 6,305 | +9% | +$57,375 | ||||||
2025-08-05 | ATRC | Atricure, Inc. | Doraiswamy Vinayak | Chief Scientific Officer | S - Sale | $36.58 | -2,500 | 71,872 | -3% | -$91,450 | ||||||
2025-08-06 | IRMD | Iradimed Corp | Allen Monty K | Dir | S - Sale | $69.10 | -1,102 | 19,898 | -5% | -$76,148 | ||||||
2025-08-04 | SIBN | Si-Bone, Inc. | Dunn Jeffrey W | Dir | S - Sale | $17.37 | -293 | 129,474 | 0% | -$5,091 | ||||||
2025-08-05 | IRTC | Irhythm Technologies, Inc. | Blackford Quentin S. | Pres, CEO | S - Sale | $160.54 | -30,000 | 179,038 | -14% | -$4,816,191 | ||||||
2025-08-05 | MMM | 3M Co | Reinseth Theresa E | SVP, CAO | S - Sale | $150.63 | -3,477 | 3,124 | -53% | -$523,741 | ||||||
| D | 2025-08-01 | SI | Shoulder Innovations, Inc. | Gilde Healthcare Holding B.V. | 10% | P - Purchase | $15.00 | +100,000 | 2,380,482 | +4% | +$1,500,000 | |||||
| M | 2025-08-01 | ATEC | Alphatec Holdings, Inc. | Lish Scott | COO | S - Sale | $13.48 | -70,604 | 674,332 | -9% | -$952,083 | |||||
| M | 2025-08-01 | ATEC | Alphatec Holdings, Inc. | Marshall Tyson Eliot | GC, CORP. SEC. | S - Sale | $13.70 | -30,970 | 438,331 | -7% | -$424,200 | |||||
2025-08-04 | IRTC | Irhythm Technologies, Inc. | Smith Mervin | EVP Strategic Business Ops | S - Sale | $164.36 | -616 | 15,838 | -4% | -$101,246 | ||||||
2025-08-04 | IRTC | Irhythm Technologies, Inc. | Patterson Chad | Chief Commercial Officer | S - Sale | $164.36 | -2,707 | 46,222 | -6% | -$444,922 | ||||||
2025-08-04 | RVP | Retractable Technologies Inc | Shaw Thomas J | Pres, CEO, 10% | P - Purchase | $0.72 | +30,881 | 16,360,813 | 0% | +$22,102 | ||||||
| D | 2025-08-01 | SI | Shoulder Innovations, Inc. | Carusi Michael A | Dir | P - Purchase | $15.00 | +266,666 | 1,892,802 | +16% | +$3,999,990 | |||||
2025-08-01 | SI | Shoulder Innovations, Inc. | Buchholz Richard | Dir | P - Purchase | $15.00 | +5,000 | 12,666 | +65% | +$75,000 | ||||||
| D | 2025-08-01 | SI | Shoulder Innovations, Inc. | Lsv Associates Ii, LLC | Former 10% Owner | P - Purchase | $15.00 | +266,666 | 1,885,136 | +16% | +$3,999,990 | |||||
| D | 2025-08-01 | SI | Shoulder Innovations, Inc. | Pardo Geoffrey B | Dir, 10% | P - Purchase | $15.00 | +100,000 | 2,388,148 | +4% | +$1,500,000 | |||||
| D | 2025-08-01 | SI | Shoulder Innovations, Inc. | Tansey Casey M | Dir, 10% | P - Purchase | $15.00 | +40,000 | 2,740,787 | +1% | +$600,000 | |||||
2025-08-01 | SI | Shoulder Innovations, Inc. | Points Jeffrey S. | CFO | P - Purchase | $15.00 | +50 | 37,631 | 0% | +$750 | ||||||
| D | 2025-08-01 | RMD | Resmed Inc | Sandercock Brett | CFO | S - Sale+OE | $281.90 | -3,000 | 83,283 | -3% | -$845,700 | |||||
| D | 2025-08-01 | OBIO | Orchestra Biomed Holdings, Inc. | Perceptive Advisors LLC | 10% | P - Purchase | $2.75 | +700,000 | 5,292,556 | +15% | +$1,925,000 | |||||
2025-08-01 | RMD | Resmed Inc | Rider Michael J | Global GC | S - Sale | $281.90 | -50 | 8,486 | -1% | -$14,095 | ||||||
2025-08-04 | OBIO | Orchestra Biomed Holdings, Inc. | Hochman David P | See Remarks | P - Purchase | $2.75 | +20,000 | 903,931 | +2% | +$55,000 | ||||||
| D | 2025-08-01 | BSX | Boston Scientific Corp | Fitzgerald Joseph Michael | EVP, Group Pres, Cardiology | S - Sale+OE | $104.63 | -50,000 | 183,576 | -21% | -$5,231,670 | |||||
| D | 2025-08-01 | BSX | Boston Scientific Corp | Butcher Arthur C | EVP,Grp Pres, MedSurg, APAC | S - Sale+OE | $104.63 | -17,313 | 36,955 | -32% | -$1,811,520 | |||||
2025-08-01 | RVP | Retractable Technologies Inc | Shaw Thomas J | Pres, CEO, 10% | P - Purchase | $0.70 | +1,575 | 16,329,932 | 0% | +$1,107 | ||||||
2025-07-30 | AURX | Nuo Therapeutics, Inc. | Sheedy Charles E | 10% | P - Purchase | $1.50 | +133,333 | 11,574,198 | +1% | +$200,000 | ||||||
2025-07-30 | NSPR | Inspiremd, Inc. | Roubin Gary S | Dir | P - Purchase | $2.42 | +41,322 | 608,425 | +7% | +$99,999 | ||||||
2025-07-30 | NSPR | Inspiremd, Inc. | Kester Thomas J | Dir | P - Purchase | $2.42 | +30,991 | 420,758 | +8% | +$74,998 | ||||||
2025-07-30 | NSPR | Inspiremd, Inc. | Slosman Marvin | CEO, Pres | P - Purchase | $2.42 | +10,330 | 2,420,866 | 0% | +$24,999 | ||||||
2025-07-30 | NSPR | Inspiremd, Inc. | Stuka Paul | Dir | P - Purchase | $2.42 | +20,661 | 804,479 | +3% | +$50,000 | ||||||
2025-07-31 | RVP | Retractable Technologies Inc | Shaw Thomas J | Pres, CEO, 10% | P - Purchase | $0.71 | +5,339 | 16,328,357 | 0% | +$3,816 | ||||||
2025-07-30 | RVP | Retractable Technologies Inc | Shaw Thomas J | Pres, CEO, 10% | P - Purchase | $0.74 | +27,288 | 16,323,018 | 0% | +$20,079 | ||||||
2025-07-29 | NVCR | Novocure Ltd | Brackmann Christoph | CFO | P - Purchase | $11.59 | +20,000 | 141,150 | +17% | +$231,800 | ||||||
2025-07-29 | BSX | Boston Scientific Corp | Fujimori Yoshiaki | Dir | S - Sale | $106.99 | -2,901 | 2,081 | -58% | -$310,378 | ||||||
2025-07-28 | DXCM | Dexcom Inc | Stern Sadie | EVP, CHRO | S - Sale | $88.99 | -1,466 | 106,689 | -1% | -$130,459 | ||||||
2025-07-25 | BSX | Boston Scientific Corp | Ludwig Edward J | Dir | S - Sale | $106.03 | -4,000 | 18,479 | -18% | -$424,120 | ||||||
| D | 2025-07-23 | PEN | Penumbra Inc | Elsesser Adam | CEO, Pres | S - Sale+OE | $233.16 | -16,150 | 723,840 | -2% | -$3,765,574 | |||||
| D | 2025-07-24 | CARL | Carlsmed, Inc. | B Capital Group Management, L.P. | 10% | P - Purchase | $15.00 | +1,333,333 | 8,321,763 | +19% | +$19,999,995 | |||||
| D | 2025-07-24 | CARL | Carlsmed, Inc. | Sidow Kevin | Dir | P - Purchase | $15.00 | +13,333 | 59,566 | +29% | +$199,995 |
| A | Amended filing |
| D | Derivative transaction in filing (usually option exercise) |
| E | Error detected in filing |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |